US FDA News: Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination

Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Clobetasol Propionate Ointment USP, 0.05% packaged in 60 g tubes, to the consumer level. This recall ONLY applies to tubes labeled with “Lot AC13786” and “Exp Dec 2022”. No other lots of this product
Read more: Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination

Pharma Reviews: Real estate in long time upcycle; housing to recover fully: Industry - Fortune India

India's office sector is coming out of the woods too, with demand back to pre-record levels. This recovery is expected to continue in 2022, even if ...
Read more: Real estate in long time upcycle; housing to recover fully: Industry - Fortune India

Pharma Reviews: Dr Reddy Laboratories : receives DCGI approval to launch Molnupiravir capsules 200mg ...

Hyderabad, India, December 28, 2021For Immediate Release ... the Indian pharmaceutical industry, a Dr. Reddy's-led consortium of pharma companies ...
Read more: Dr Reddy Laboratories : receives DCGI approval to launch Molnupiravir capsules 200mg ...

Pharma Reviews: Sun Pharma gets DCGI nod to market molnupiravir for COVID-19 treatment - The Economic Times

... therapies available for treating Covid-19 patients, Sun Pharmaceutical Industries CEO (India Business) Kirti Ganorkar said in a statement.
Read more: Sun Pharma gets DCGI nod to market molnupiravir for COVID-19 treatment - The Economic Times

Pharma Reviews: Dr Reddy labs get DCGI approval to manfacture & market anti-viral drug 'Molnupiravir'

In a first-of-its-kind collaboration in the Indian pharmaceutical industry, Dr. Reddy's-led consortium of pharma companies collaborated to jointly ...
Read more: Dr Reddy labs get DCGI approval to manfacture & market anti-viral drug 'Molnupiravir'

Pharma Reviews: Torrent Pharma to launch Molnupiravir under Molnutor brand name to treat COVID-19 - The ...

The Drugs Controller General of India (DCGI), based on the review of clinical data of Molnupiravir, has approved the drug for the treatment of ...
Read more: Torrent Pharma to launch Molnupiravir under Molnutor brand name to treat COVID-19 - The ...

Pharma Reviews: Optimus Pharma to launch COVID-19 drug Molnupiravir shortly, Sun Pharma to market it

Hyderabad: Optimus Pharma on Tuesday said it would be launching its frontline COVID-19 medication Molnupiravir in the Indian market in a day or ...
Read more: Optimus Pharma to launch COVID-19 drug Molnupiravir shortly, Sun Pharma to market it

Pharma Reviews: Best 10 Biotech Companies In India 2022 - Inventiva

India's ten best biotech companies are among the best biotech and pharmaceutical companies. Companies that produce, design, ...
Read more: Best 10 Biotech Companies In India 2022 - Inventiva

Pharma Reviews: Torrent Pharma recalls 27000 bottles of BP lowering medicine in the US

Torrent Pharma is recalling more than 27,000 bottles of its generic drug, used in lowering high blood pressure, in the US market.
Read more: Torrent Pharma recalls 27000 bottles of BP lowering medicine in the US

Pharma Reviews: Global collaboration, Digitisation to fuel Pharmaceutical market's growth in India, Health ...

With the year 2021 coming to an end, the industry can be seen realigning efforts towards developing cures and treatments for other diseases that ...
Read more: Global collaboration, Digitisation to fuel Pharmaceutical market's growth in India, Health ...

Pharma Reviews: Taking Stock | Market Ends Higher Amid Volatility; IT, Pharma And Realty Stocks Gain - Moneycontrol

Indian benchmark indices erased the losses of the previous session and ended higher on December 27 supported by information technology, pharma, ...
Read more: Taking Stock | Market Ends Higher Amid Volatility; IT, Pharma And Realty Stocks Gain - Moneycontrol

Pharma Reviews: C Com reinvents social media contextual marketing for Pharma industry - BioSpectrum India

The Indian pharma companies cater to over 50% of global vaccine demands, and 40% of generic drugs consumed in the US as well as 25% of all ...
Read more: C Com reinvents social media contextual marketing for Pharma industry - BioSpectrum India

Pharma Reviews: Himachal focussing on farming, pharma: Modi - UNITED NEWS OF INDIA

... Himachal Pradesh with helping India remain the pharmacy of the world. ... on the food processing industry, farming and pharmaceutical sector.
Read more: Himachal focussing on farming, pharma: Modi - UNITED NEWS OF INDIA

Pharma Reviews: Third wave of COVID in India likely to peak in early Feb: Study - Express Pharma

The third wave of the COVID-19 pandemic in India may peak by February 3, ... the No.1 Business News Magazine for the pharmaceutical industry.
Read more: Third wave of COVID in India likely to peak in early Feb: Study - Express Pharma

Pharma Reviews: Indian Pharma Industry's response to the pandemic and outlook for the new year, Health ...

During the COVID 19 pandemic, the Indian pharmaceutical industry has been ensuring that there is uninterrupted supply of medicines to patients across ...
Read more: Indian Pharma Industry's response to the pandemic and outlook for the new year, Health ...

Pharma Reviews: E-pharmacies, medtech to help cut health expenses - Times of India

India Business News: Vaccines, medicines and diagnostics — all key ... The Indian pharma industry and the healthcare fraternity at large, ...
Read more: E-pharmacies, medtech to help cut health expenses - Times of India

Pharma Reviews: Ahead of Market: 12 things that will decide stock action on Monday - The Economic Times

The MACD showed bearish signs on the counters of Torrent Pharma, India Cements, DB Realty, Reliance Industries, Exide Industries, ...
Read more: Ahead of Market: 12 things that will decide stock action on Monday - The Economic Times

Pharma Reviews: India to begin vaccination for children aged 15 years and up, booster doses for some from January

Download The Economic Times News App to get Daily Market Updates & Live Business News. ...moreless. ETPrime stories of the day ...
Read more: India to begin vaccination for children aged 15 years and up, booster doses for some from January

Pharma Reviews: India Inc raises over Rs 9 lakh crore through equity, debt issuances in 2021 - The Economic Times

"Indian debt markets are mostly tapped by the financial sector companies who use funds for onward lending (as the economic cycle gathers pace) and ...
Read more: India Inc raises over Rs 9 lakh crore through equity, debt issuances in 2021 - The Economic Times

Pharma Reviews: Covaxin receives approval for emergency use in 12-18 years old children - Express Pharma

Hyderabad-based pharmaceutical company, Bharat Biotech has announced ... India's leading business fortnightly for the pharmaceutical industry.
Read more: Covaxin receives approval for emergency use in 12-18 years old children - Express Pharma

Pharma Reviews: Indian startups plan big hiring in 2022 - Fortune India

Not surprisingly, most startups have allocated the bulk of the recruitment budgets to product, tech and data science branches. Infra.Market that ...
Read more: Indian startups plan big hiring in 2022 - Fortune India

Pharma Reviews: India as health industry leader is a matter of strategic importance - The Sunday Guardian Live

Ensuring India remains the leader in vaccines and pharmaceuticals in the face of attack on it by China and the “Big Pharma” is of vital importance ...
Read more: India as health industry leader is a matter of strategic importance - The Sunday Guardian Live

Pharma Reviews: ADIF urges RBI to ensure card tokenisation readiness across banks - BILKULONLINE

The Alliance of Digital India Foundation (ADIF) on Friday welcomed the Reserve ... “In addition to tokenisation, industry stakeholders may devise ...
Read more: ADIF urges RBI to ensure card tokenisation readiness across banks - BILKULONLINE

Pharma Reviews: Predictions 2022: The pandemic and beyond: How the pharma industry is shaping up for the future

The government is a key stakeholder to enable the advancement of the Indian pharmaceutical industry. Recently, the government launched notable ...
Read more: Predictions 2022: The pandemic and beyond: How the pharma industry is shaping up for the future

Pharma Reviews: MedPlus shows pharma retail has lots more in store - The Economic Times

Amidst the Covid pandemic, MedPlus Health Service became the first standalone pharmacy retail chain to get listed on the Indian bourses.
Read more: MedPlus shows pharma retail has lots more in store - The Economic Times

Pharma Reviews: retail pharmacy industry: What's in store – A look at the retail pharmacy industry in India ...

The Indian pharmaceutical market forms a significant part of the healthcare sector's ecosystem. According to the National Health Accounts, ...
Read more: retail pharmacy industry: What's in store – A look at the retail pharmacy industry in India ...

Pharma Reviews: Pharma will give momentum in 2022, says OPPI - Medical Dialogues

... COVID-19 vaccine requirements, the Indian pharma and healthcare industry is... ... Organisation of Pharmaceutical Producers of India (OPPI) ...
Read more: Pharma will give momentum in 2022, says OPPI - Medical Dialogues

Pharma Reviews: Covid-19: How will Pfizer's oral antiviral treatment drug Paxlovid come to India? - The ...

Indian giants Sun Pharmaceutical Industries, Optimus Pharma, and Dr Reddy's Laboratories are exploring the possibility of manufacturing the pill, ...
Read more: Covid-19: How will Pfizer's oral antiviral treatment drug Paxlovid come to India? - The ...

Pharma Reviews: Digital Transformation: Altering The Dna Of Life Sciences - CNBCTV18 Business News

The life sciences industry has furthered the notion of digital ... Talking about the impact of COVID on the Indian pharma industries and what lies ...
Read more: Digital Transformation: Altering The Dna Of Life Sciences - CNBCTV18 Business News

Pharma Reviews: Medical devices & bulk drugs industry to have more opportune days ahead : Dr Yuvaraj

Aurobindo Pharma Director M.Madan Mohan Reddy in his special address said Indian pharma industry has great potential to export given the size of ...
Read more: Medical devices & bulk drugs industry to have more opportune days ahead : Dr Yuvaraj

Pharma Reviews: Indian API segment sees PE, strategic inflow nearly doubling in 2021 - The Economic Times

“India began its journey in becoming a key supply hub in the global pharmaceutical ecosystem during the 1970s with a strong bulk drug industry as ...
Read more: Indian API segment sees PE, strategic inflow nearly doubling in 2021 - The Economic Times

Pharma Reviews: NATCO Pharma: Chemistry of Compassion, Capital and Creativity - Moneylife

Being in the pharma industry carries the responsibility of a high ... which is higher than the average distribution among the Indian corporates.
Read more: NATCO Pharma: Chemistry of Compassion, Capital and Creativity - Moneylife

Pharma Reviews: Fuelling pharma innovation: Govt's draft R&D policy a welcome, inclusive step forward - The ...

Our founder, the late Dr. Anji Reddy, was a visionary who built Dr. Reddy's Laboratories into one of India's foremost pharma companies with a ...
Read more: Fuelling pharma innovation: Govt's draft R&D policy a welcome, inclusive step forward - The ...

Pharma Reviews: The Medicine Box | Increased Awareness On Wellness, Immunity Leading To Growth Of ...

The domestic pharma market or the IPM has grown from $17 billion in FY17 to $21 billion in FY21. In FY21, the growth in India's pharma industry, ...
Read more: The Medicine Box | Increased Awareness On Wellness, Immunity Leading To Growth Of ...

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

The FDA issued an emergency use authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in certain adults.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

US FDA News: FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

The FDA authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products, which help reduce exposure to and consumption of nicotine for smokers who use them.
Read more: FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

Pharma Reviews: Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News ...

Bharti Airtel was the top laggard falling 0.93%, followed by Sun Pharma, Maruti Suzuki India, and Ultratech Cement. India VIX fell 4.52% to close ...
Read more: Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News ...

Pharma Reviews: PLI scheme to spur growth in pharma sector - Telangana Today

Addressing Pharma Mart 2021 conference `Pharma manufacturing industry: Challenges and opportunities' organised by the Confederation of Indian ...
Read more: PLI scheme to spur growth in pharma sector - Telangana Today

Pharma Reviews: Govt adopted a facilitative approach under PLI scheme for Pharma sector - PSU Connect

New Delhi: Confederation of Indian Industry organized a Conference on Pharma Mart 2021 with a theme focusing on “Pharma Manufacturing Industry: ...
Read more: Govt adopted a facilitative approach under PLI scheme for Pharma sector - PSU Connect

Pharma Reviews: Sensex surges 600 pts, Nifty reclaims 16,900; Airtel, RIL, SBI, L&T shine - Fortune India

The market sentiment was boosted by gains in index heavyweights such as Reliance Industries, Sun Pharma, SBI, Bharti Airtel, Bajaj Finance, Tata Steel ...
Read more: Sensex surges 600 pts, Nifty reclaims 16,900; Airtel, RIL, SBI, L&T shine - Fortune India

Pharma Reviews: analytica Anacon India and India Lab Expo: Successful restart of lab & analysis industry

The conference partner, the Indian Pharmaceutical Alliance (IPA), also organized the session on Lab of Future. Online—the exhibition beyond three ...
Read more: analytica Anacon India and India Lab Expo: Successful restart of lab & analysis industry

Pharma Reviews: The brave women who shape pharma journalism in India. And how even the pandemic ...

This is the story of India's gritty women pharma journalists and how they've ... Communicate & build a connection with great minds of the industry.
Read more: The brave women who shape pharma journalism in India. And how even the pandemic ...

Pharma Reviews: Market LIVE Updates: Indices Extend Gains, Sensex Gains 500 Pts - Moneycontrol

Stock Market LIVE Updates: Among sectors, auto, capital goods, pharma, metal, realty and PSU bank up 1-2 percent. BSE midcap and smallcap indices ...
Read more: Market LIVE Updates: Indices Extend Gains, Sensex Gains 500 Pts - Moneycontrol

Pharma Reviews: Discerning the next frontier for quality excellence in Indian pharma industry - Express Pharma

Express Pharma, in association with SAP India, as part of the Industry Knowledge Exchange Forum, invited pharma quality veteran Dr Ranjana Pathak, ...
Read more: Discerning the next frontier for quality excellence in Indian pharma industry - Express Pharma

Pharma Reviews: The Pivot to Digital Retail will Unlock New Business Opportunities for SMBs in India

India's attractive demographic dividend, rising 4G smartphone ... a small size in India's retail pharma market that is pegged at US$ 25 billion.
Read more: The Pivot to Digital Retail will Unlock New Business Opportunities for SMBs in India

Pharma Reviews: Pharma Mart 2021 to be held in Visakhapatnam on Dec 23 - UNITED NEWS OF INDIA

Uniindia: Visakhapatnam, Dec 21 (UNI) Confederation of Indian Industry (CII) Andhra Pradesh is organizing the Pharma Mart 2021, a Conference on ...
Read more: Pharma Mart 2021 to be held in Visakhapatnam on Dec 23 - UNITED NEWS OF INDIA

Pharma Reviews: Smart Manufacturing Conclave: An insight into Indian manufacturing sector - Express Computer

Next on the event agenda was a session by Nikhil Shembekar, Head, Digital, Analytics, Supply Chain and Emerging Technologies, SUN Pharma who shared ...
Read more: Smart Manufacturing Conclave: An insight into Indian manufacturing sector - Express Computer

Pharma Reviews: Stock market update: Nifty Pharma index advances 0.75% - The Economic Times

The Nifty Pharma index closed 0.75 per cent up at 13282.85. ... Glenmark Pharmaceuticals(down 0.49 per cent) and Abbott India(down 0.06 per cent) ...
Read more: Stock market update: Nifty Pharma index advances 0.75% - The Economic Times

Pharma Reviews: "Entry of pharma companies & large corporate chain hospitals into diagnostics is expanding ...

In conversation with Dr Sandeep Sewlikar, Head - Medical and Scientific Affairs, Roche Diagnostics India, Mumbai.
Read more: "Entry of pharma companies & large corporate chain hospitals into diagnostics is expanding ...

Pharma Reviews: Stock market update: Nifty Pharma index advances 0.82% in an upbeat market - The ...

The Nifty Pharma index was trading 0.82 per cent up at 13293.1. ... Sun Pharmaceutical Industries(up 1.94 per cent), Gland Pharma(up 1.56 per ...
Read more: Stock market update: Nifty Pharma index advances 0.82% in an upbeat market - The ...

Pharma Reviews: Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio - BioSpectrum India

Investment in biologics reflects the company's global commitment to this fast-growing segment of the pharma industry.
Read more: Piramal Pharma invests Rs 101.77 Cr in CDMO Yapan Bio - BioSpectrum India

Pharma Reviews: Piramal Pharma invests Rs 101.77 cr for minority stake in Yapan Bio - The Financial Express

“During the past decade, biologics and their accompanying development services are the fastest-growing segments of the CDMO market. ”This investment, ...
Read more: Piramal Pharma invests Rs 101.77 cr for minority stake in Yapan Bio - The Financial Express

Pharma Reviews: Moderna says booster dose of its COVID-19 vaccine appears protective against Omicron ...

Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry.
Read more: Moderna says booster dose of its COVID-19 vaccine appears protective against Omicron ...

US FDA News: FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention

Today, the FDA approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV.
Read more: FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention

Pharma Reviews: The Future of Pharma: Are CDMOs shaping up a more holistic industry - Times of India

The Indian pharma industry has witnessed a tremendous growth in the last two decades driven by its strength in the global generics space.
Read more: The Future of Pharma: Are CDMOs shaping up a more holistic industry - Times of India

Pharma Reviews: Strengthening India s Pharma Sector As National Security Imperative-Karan Singh - BW ...

Strengthening India's Pharma Sector As National Security Imperative. The PLI scheme is a step in the right direction in fulfilling India's domestic ...
Read more: Strengthening India s Pharma Sector As National Security Imperative-Karan Singh - BW ...

Pharma Reviews: Centre working on policy to encourage research in pharma sector: Mansukh Mandaviya ...

He said India has got skill, manpower and trust to attract global investment in the pharma sector. The number of health and wellness centres ...
Read more: Centre working on policy to encourage research in pharma sector: Mansukh Mandaviya ...

Pharma Reviews: Largecap It, Pharma Stocks Can Be Pockets To Hide In This Market, Says Invesco'S Taher Badshah

The anticipation of a quicker than expected pullback of stimulus by the Reserve Bank of India (RBI) has spooked markets, said Taher Badshah, ...
Read more: Largecap It, Pharma Stocks Can Be Pockets To Hide In This Market, Says Invesco'S Taher Badshah

Pharma Reviews: Cipla receives USFDA nod to market Lanreotide injection in US market - Express Pharma

By Press Trust of India On Dec 20, 2021. 0 8. Share. Read Article. Cipla yesterday said it has received approval from the US health regulator to ...
Read more: Cipla receives USFDA nod to market Lanreotide injection in US market - Express Pharma

Pharma Reviews: Healthcare Industry 4.0 – It's time to adapt and time to transform - ET HealthWorld

Globally, India ranks 3rd in terms of pharmaceutical production volume and 14th by value. Statistically speaking, the domestic pharmaceutical industry ...
Read more: Healthcare Industry 4.0 – It's time to adapt and time to transform - ET HealthWorld

Pharma Reviews: ArcelorMittal Nippon will continue to invest in India: Group CEO Aditya Mittal - Economic Times

ArcelorMittal, led by LN Mittal, officially set foot in India by closing a ... Business News › Industry › Ind'l Goods/Svs › Steel ›ArcelorMittal ...
Read more: ArcelorMittal Nippon will continue to invest in India: Group CEO Aditya Mittal - Economic Times

Pharma Reviews: Govt working on policy to encourage research in pharma sector, says Mandaviya - BusinessToday

Mandaviya lamented that although India is making generic medicines available to the world on a large scale, people of the country are consuming ...
Read more: Govt working on policy to encourage research in pharma sector, says Mandaviya - BusinessToday

Pharma Reviews: Minister hard sells pharma opportunities; industry leaders list down challenges, snags

Pharma companies listed the issues and challenges that plague the development of the sector in India even as Union Minister of Health & Family ...
Read more: Minister hard sells pharma opportunities; industry leaders list down challenges, snags

Pharma Reviews: People should know what they want to achieve - Express Pharma

Suneela Thatte, VP and Head – R&D, India, Merck KGaA, in an interaction ... business management and policy advocacy in the biopharma industry.
Read more: People should know what they want to achieve - Express Pharma

Pharma Reviews: Akums Drugs & Pharmaceuticals bags prestigious Business Excellence Award 2021 - ANI News

New Delhi [India], December 17 (ANI/PNN): Akums Drugs and ... to the gamut of visitors globally from the pharma and healthcare industries.
Read more: Akums Drugs & Pharmaceuticals bags prestigious Business Excellence Award 2021 - ANI News

Pharma Reviews: Centre working on policy to encourage research in pharma sector, says Mandaviya; stresses ...

Speaking at an event on pharmaceutical sector organised here in the run ... He lamented that although India is making generic medicines available ...
Read more: Centre working on policy to encourage research in pharma sector, says Mandaviya; stresses ...

Pharma Reviews: Share Market Highlights: Sensex tanks 889 pts to close at 57011, Nifty dives below 17000

India VIX closed 3% higher. (Image: REUTERS). Share Market News Today | Sensex, Nifty, Share Prices Highlights: Bears forced domestic markets to ...
Read more: Share Market Highlights: Sensex tanks 889 pts to close at 57011, Nifty dives below 17000

Pharma Reviews: Akums Drugs & Pharmaceuticals bags prestigious Business Excellence Award 2021 - ThePrint

Indian Pharma Expo (IPE) provides an opportunity for the participating companies to display their products & services to the gamut of visitors ...
Read more: Akums Drugs & Pharmaceuticals bags prestigious Business Excellence Award 2021 - ThePrint

Pharma Reviews: Sun Pharma vs Dr Reddy's: Which is Better? - Mint

The growth in the industry would partly be driven by the growth in exports of generic medicines as several drugs are set to come off patent. India's ...
Read more: Sun Pharma vs Dr Reddy's: Which is Better? - Mint

Pharma Reviews: Sensex, Nifty end higher led by IT stocks; banks, pharma, metals, auto weigh - Mint

Market closing: Indian equities ended higher amid a volatile session on Thursday. World stocks gained after the Fed projected three quarter-point ...
Read more: Sensex, Nifty end higher led by IT stocks; banks, pharma, metals, auto weigh - Mint

Pharma Reviews: USFDA approves Sun Pharma's Generic Amphotericin B Liposome injection - IndiaInfoline

Dec 16, 2021 11:12 IST | India Infoline News Service. A ⁺ A ^-. Read Full Story. Sun Pharma. Sun Pharmaceutical Industries announced that one of ...
Read more: USFDA approves Sun Pharma's Generic Amphotericin B Liposome injection - IndiaInfoline

Pharma Reviews: Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June - Express Pharma

The Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2022) ... India's pharmaceutical industry can meet requirements of the world, ...
Read more: Pharmaceutical Manufacturing And Packaging Congress 2022 to be held in June - Express Pharma

Pharma Reviews: 10th Vibrant Gujarat Global Summit 2022 to be held in January - Express Pharma

... senior industry leaders and technocrats deliberating upon ways to reduce India's dependence upon imports of pharmaceutical bulk drug and ...
Read more: 10th Vibrant Gujarat Global Summit 2022 to be held in January - Express Pharma

Pharma Reviews: Market LIVE Updates: Sensex, Nifty Trade Flat Amid Volatility; IT Stocks Gain, Realty, Pharma Drag

Ashoka Buildcon had submitted offer to Howe Engineering Projects (India) Private Limited in respect of the Project viz. work of construction of ...
Read more: Market LIVE Updates: Sensex, Nifty Trade Flat Amid Volatility; IT Stocks Gain, Realty, Pharma Drag

Pharma Reviews: Sun Pharma Wins U.S. FDA Approval For Fungal Injection Shot: Analysts' Take - Bloomberg Quint

One of India's largest drugmaker's wholly-owned subsidiaries has ... Sun Pharmaceutical Industries Ltd.'s generic anti-fungal injection is an ...
Read more: Sun Pharma Wins U.S. FDA Approval For Fungal Injection Shot: Analysts' Take - Bloomberg Quint

US FDA News: FDA Approves First Drug to Prevent Graft Versus Host Disease

The FDA approved the first drug for the prevention of acute graft versus host disease, a condition that occurs when donor bone marrow or stem cells attack the graft recipient, in combination with certain immunosuppressants.
Read more: FDA Approves First Drug to Prevent Graft Versus Host Disease

Pharma Reviews: India's pharmaceutical industry can meet requirements of the world, says WTO Director General

Dr Ngozi Okonjo-Iweala, Director General, World Trade Organisation (WTO) has said that India's pharmaceutical industry can meet the requirements ...
Read more: India's pharmaceutical industry can meet requirements of the world, says WTO Director General

Pharma Reviews: Stock Market Live Updates: Sensex, Nifty Trade Lower; It, Pharma Drag, Hp Adhesives Ipo ...

Stock Market LIVE Updates: Indian equity benchmarks Sensex and Nifty50 dropped on Wednesday. Losses in IT, pharma and FMCG shares pulled the ...
Read more: Stock Market Live Updates: Sensex, Nifty Trade Lower; It, Pharma Drag, Hp Adhesives Ipo ...

Pharma Reviews: Venus Remedies makes the cut for PLI scheme - Express Pharma

Venus Remedies has figured among the select pharmaceutical firms in India ... to get first-to-market advantage within HIF-PHI class in India, ...
Read more: Venus Remedies makes the cut for PLI scheme - Express Pharma

Pharma Reviews: Keynote address: Indian Pharmacopoeia – The contextual relevance - Express Pharma

But, this has also increased complexities in R&D, manufacturing and regulation. Therefore, pharma companies have to adapt to these changes, strategise ...
Read more: Keynote address: Indian Pharmacopoeia – The contextual relevance - Express Pharma

Pharma Reviews: KOREA PACK & ICPI WEEK (Int'l Cosmetic and Pharmaceutical Industry Week) 2022 to ...

Business Wire India KOREA PACK and concurrent event ICPI WEEK (Int'l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid ev...
Read more: KOREA PACK & ICPI WEEK (Int'l Cosmetic and Pharmaceutical Industry Week) 2022 to ...

Pharma Reviews: The coexistence between the retail pharmacy stores and their e-commerce peers, Health ...

The Indian retail pharmacy market witnesses various gaps. ... The solution to upscale the Indian pharma industry is to bring about solutions so ...
Read more: The coexistence between the retail pharmacy stores and their e-commerce peers, Health ...

Pharma Reviews: 8 more drug manufacturers bag approval under PLI scheme - Medical Dialogues

The Indian pharmaceutical industry is the 3rd largest in the world by volume. It has high market presence in several advanced economies such as ...
Read more: 8 more drug manufacturers bag approval under PLI scheme - Medical Dialogues

Pharma Reviews: Eli Lilly appoints Vineet Gupta as General Manager of its India affiliate with effect from January 2022

Vineet Gupta joined Eli Lilly in 2010 as Marketing Director for India, ... know market's Top Gainers, Top Losers & Best Equity Funds.
Read more: Eli Lilly appoints Vineet Gupta as General Manager of its India affiliate with effect from January 2022

Pharma Reviews: Veeva strengthens leadership team with addition of general manager for Vault Quality in ... - ThePrint

“India is one of the largest manufacturers and exporters of ... “I am excited to support the Indian Pharma industry to help accelerate quality ...
Read more: Veeva strengthens leadership team with addition of general manager for Vault Quality in ... - ThePrint

Pharma Reviews: Sensex Trades Slightly Lower, Nifty Below 17.5k; Titan, Tech Mahindra Top Losers - Mint

Indian share markets trade marginally lower. ... In news from the pharma sector, Dr Reddy's Lab is among the top buzzing stocks today.
Read more: Sensex Trades Slightly Lower, Nifty Below 17.5k; Titan, Tech Mahindra Top Losers - Mint

Pharma Reviews: Pfizer Covid vaccine provides partial protection against Omicron: Study - Express Pharma

By Press Trust of India On Dec 9, 2021. 0 10. Share. Read Article. The Pfizer COVID-19 vaccine provides less immunity against Omicron than from ...
Read more: Pfizer Covid vaccine provides partial protection against Omicron: Study - Express Pharma

Pharma Reviews: Chandrasekhar, new DST Secretary is firmly rooted to Hyderabad - The Siasat Daily

One of them is developing Innovative Processes &Technologies for Indian Pharmaceutical and Agrochemical Sector Industries (INPROTICS-Pharma and ...
Read more: Chandrasekhar, new DST Secretary is firmly rooted to Hyderabad - The Siasat Daily

Pharma Reviews: Ipca, AstraZeneca, Torrent, Sun Pharma outshine Indian pharma market in Nov - Mint

The Indian pharma market grew 6.1% during November led by continued traction in the chronic segment. The acute segment also grew on a low base of ...
Read more: Ipca, AstraZeneca, Torrent, Sun Pharma outshine Indian pharma market in Nov - Mint

Pharma Reviews: Stock market update: Nifty Pharma index advances 1.17% in an upbeat market

Sun Pharmaceutical Industries(up 2.32 per cent), Granules India(up 2.3 per cent), Ipca Laboratories(up 2.11 per cent), Cadila Healthcare(up 1.78 ...
Read more: Stock market update: Nifty Pharma index advances 1.17% in an upbeat market

Pharma Reviews: BDR Pharmaceuticals launches India's first generic Midostaurin (MSTARIN) to treat ...

BDR Pharma has launched India's first Generic- Midostaurin under the brand name MSTARIN, ... How pharma companies can avoid cyber threats.
Read more: BDR Pharmaceuticals launches India's first generic Midostaurin (MSTARIN) to treat ...

US FDA News: Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution USP 4% Due to Super Potency

Buena, NJ, Teligent Pharma, Inc. is voluntarily recalling two lots of Lidocaine HCl Topical Solution USP 4%, 50ml in a screw cap glass bottle listed in the table below to the user level. The product is being recalled because the firms testing has found it to be super potent based on an Out of Specif
Read more: Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution USP 4% Due to Super Potency

US FDA News: Edge Pharma, LLC Issues Voluntary Nationwide Recall of All Drug Products Due to Lack of Sterility Assurance

Colchester, VT, Edge Pharma, LLC is voluntarily recalling all lots of all drugs compounded at Edge Pharma, LLC to the consumer level. All products are being recalled due to process issues that could lead to a lack of sterility assurance for products intended to be sterile and could impact the safety
Read more: Edge Pharma, LLC Issues Voluntary Nationwide Recall of All Drug Products Due to Lack of Sterility Assurance

Pharma Reviews: GSK Pharma - Long-Term Outlook Remains Positive: HDFC Securities Retail Research ...

GlaxoSmithKline Pharmaceuticals is one of the leading multi national pharma companies with a market share of ~3% in the Indian Pharma market.
Read more: GSK Pharma - Long-Term Outlook Remains Positive: HDFC Securities Retail Research ...

Pharma Reviews: How pharma companies can avoid cyber threats

The pharmaceutical industry is an attractive target for cybercriminals as ... visibility is by establishing a cloud-native security architecture.
Read more: How pharma companies can avoid cyber threats

Pharma Reviews: Dr Jyotsna Dhawan joins DBT/India Alliance as CEO - Express Pharma

DBT/Wellcome Trust India Alliance (India Alliance) has appointed Dr Jyotsna Dhawan as its ... Aurobindo and Unichem recall products in US market.
Read more: Dr Jyotsna Dhawan joins DBT/India Alliance as CEO - Express Pharma

Pharma Reviews: LSSSDC launches Professional Development Programs in collaboration with GIZ for ...

In order to ease industry challenges with technology and e-skilling to upgrade the skill set of pharma professionals, Life Sciences Sector Skill ...
Read more: LSSSDC launches Professional Development Programs in collaboration with GIZ for ...

Pharma Reviews: Lok Sabha passes NIPER (Amendment) Bill, 2021 to strengthen research and education in ...

The current bill will amend the National Institute of Pharmaceutical ... importance to strengthen research and education in the pharma sector.
Read more: Lok Sabha passes NIPER (Amendment) Bill, 2021 to strengthen research and education in ...

Pharma Reviews: india: India's healthcare sector: investment opportunities and outlook, Health News, ET HealthWorld

There are significant and promising investment opportunities in India's pharmaceutical industry that includes over-the-counter drugs, vaccines and ...
Read more: india: India's healthcare sector: investment opportunities and outlook, Health News, ET HealthWorld

Pharma Reviews: CPhI India concludes the 2021 Hybrid Edition of CPhI – P-MEC Expo along with Informa ... - ThePrint

India's pharmaceutical market is in the midst of a growth spurt, ... The pharma industry is anticipated to have a steady growth trajectory and the ...
Read more: CPhI India concludes the 2021 Hybrid Edition of CPhI – P-MEC Expo along with Informa ... - ThePrint

Pharma Reviews: Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 ...

Both companies have achieved close to 90 per cent of present production ... As communicated by the Serum Institute of India (SII), the current ...
Read more: Covishield current monthly production capacity 250-275 million doses, Covaxin 50-60 ...

US FDA News: Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates

Foster City, CA, Gilead Sciences Inc. (Nasdaq: GILD) today announced it is voluntarily recalling two lots of Veklury® (remdesivir 100 mg for injection) to the user level. Gilead Sciences Inc. received a customer complaint, confirmed by the firm’s investigation, of the presence of glass particulates.
Read more: Gilead Issues A Voluntary Nationwide Recall of Two Lots of Veklury® (Remdesivir) Due to Presence of Glass Particulates

Pharma Reviews: BDR Pharmaceuticals launches India's first generic Midostaurin for treatment of Leukemia ...

BDR Pharma, one of India's leading generic pharmaceutical companies has launched India's first Generic- Midostaurin under the brand name MSTARIN, ...
Read more: BDR Pharmaceuticals launches India's first generic Midostaurin for treatment of Leukemia ...

Pharma Reviews: Sputnik Light may get nod soon: RDIF - Mint

RDIF said it is actively cooperating with Indian regulatory ... leading Indian pharmaceutical companies, including Serum Institute of India (the ...
Read more: Sputnik Light may get nod soon: RDIF - Mint

Pharma Reviews: Lok Sabha passes bill to enhance status of six more institutes of pharmaceutical education, research

The Modi government constantly encouraged pharma companies and simplified process for them, resulting in an Indian firm developing a Covid vaccine ...
Read more: Lok Sabha passes bill to enhance status of six more institutes of pharmaceutical education, research

Pharma Reviews: Closing Bell: Nifty Below 17,000, Sensex Tanks 949 Points; Auto, IT, Pharma Hammered

However, a change is expected during H1 2022, which Indian market is factoring while global equities are trading mixed.
Read more: Closing Bell: Nifty Below 17,000, Sensex Tanks 949 Points; Auto, IT, Pharma Hammered

Pharma Reviews: Stock market update: Nifty Pharma index falls 0.62% in a weak market - The Economic Times

Shutterstock.com India 10-year bond yield jumped 0.38 per cent to 6.03 after trading in 6.01 - 6.04 range. NEW DELHI: The Nifty Pharma index traded ...
Read more: Stock market update: Nifty Pharma index falls 0.62% in a weak market - The Economic Times

Pharma Reviews: CPhI India concludes the 2021 Hybrid Edition of CPhI - P-MEC Expo - ANI News

New Delhi [India], December 6 (ANI/PRNewswire): Informa Pharma Intelligence, ... India's pharmaceutical market is in the midst of a growth spurt, ...
Read more: CPhI India concludes the 2021 Hybrid Edition of CPhI - P-MEC Expo - ANI News

Pharma Reviews: Diabetes major Eris Lifesciences enters India's insulin market through joint venture with MJ ...

Eris, one of India's leading players in the Oral Diabetes Care segment, will now extend its product offering to insulins and GLP1 agonists.
Read more: Diabetes major Eris Lifesciences enters India's insulin market through joint venture with MJ ...

Pharma Reviews: Eris Lifesciences enters in Indian insulin market, forms a joint venture with MJ Biopharm ...

The company stated that “Eris MJ Biopharm” has been created to leverage the significant market opportunity in Human Insulin, Analogues and GLP1 ...
Read more: Eris Lifesciences enters in Indian insulin market, forms a joint venture with MJ Biopharm ...

Pharma Reviews: Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData - Express Pharma

The pharma industry last month reported 53 deals worth $9.6 billion as compared to the last 12-month average (November 2020 to October 2021) of 97 ...
Read more: Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData - Express Pharma

Pharma Reviews: India Industrial Water Quality Analyzer Market Report 2021-2027 - Focus on Potential Of ...

The segment is expected to dominate the overall market in the forecast period as the pharma sector aims to develop water solutions stations in the ...
Read more: India Industrial Water Quality Analyzer Market Report 2021-2027 - Focus on Potential Of ...

Pharma Reviews: Firms propose to invest Rs 200 crore for pharma park in Indore - Times of India

Industries are looking for a full-fledged facility equipped with basic infrastructure to support the drug industry." Industry representatives have ...
Read more: Firms propose to invest Rs 200 crore for pharma park in Indore - Times of India

Pharma Reviews: Eris enters JV with MJ Pharma to commercialise insulins in domestic market - The Economic Times

Mumbai based MJ Biopharm is into development and commercialisation of recombinant biosimilar formulations, with manufacturing facilities in India for ...
Read more: Eris enters JV with MJ Pharma to commercialise insulins in domestic market - The Economic Times

Pharma Reviews: Eris Lifesciences forms JV with MJ Biopharm to enter India's insulin segment - BusinessToday

These categories comprise 61 per cent of the anti-diabetes market in the ... says 55 manufacturers to benefit under PLI scheme for pharma sector.
Read more: Eris Lifesciences forms JV with MJ Biopharm to enter India's insulin segment - BusinessToday

Pharma Reviews: Coping and thriving through COVID-19 - Express Pharma

The pharma industry, along with the healthcare sector in India has been significantly impacted by the outbreak of the coronavirus pandemic. Though the ...
Read more: Coping and thriving through COVID-19 - Express Pharma

Pharma Reviews: Stock market update: Nifty Pharma index falls 0.83% - The Economic Times

NEW DELHI: The Nifty Pharma index closed on a negative note on Friday. Shares of Natco Pharma(up 0.57 per cent), Alembic Pharmaceuticals(up 0.52 ...
Read more: Stock market update: Nifty Pharma index falls 0.83% - The Economic Times

Pharma Reviews: India imported raw material worth Rs 28,528.97 cr to mfg medicines last fiscal: Mandaviya | Business

The Indian pharmaceutical industry is the world's third largest by volume, providing 20-22 per cent of generic drugs globally and is one of the ...
Read more: India imported raw material worth Rs 28,528.97 cr to mfg medicines last fiscal: Mandaviya | Business

US FDA News: Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests for Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers

Laboratories should expect some false negative results because the SARS-CoV-2 virus can mutate over time and not be detected.
Read more: Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests for Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers

US FDA News: FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

FDA revised the EUA of bamlanivimab and etesevimab, administered together, to treat mild to moderate COVID-19 in all younger pediatric patients, including newborns. The drug combination is also now authorized for post-exposure prevention of COVID-19 in all pediatric patients, including newborns.
Read more: FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

US FDA News: Arrow International Inc Recalls Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7Fr, Due to Risk of Separation

The 7FR PTD Kits are used to remove clots in adult patients who have arterio-venous (AV) fistulas and synthetic dialysis grafts.
Read more: Arrow International Inc Recalls Arrow-Trerotola Over-The-Wire PTD Kit Percutaneous Thrombolytic Device: 7Fr, Due to Risk of Separation

Pharma Reviews: Brinton Pharma Gets Top Award for Pioneering an Impact on Indian Industry - Headlines of Today

Rahulkumar Darda, Chairman and Managing Director, Brinton Pharmaceuticals received the coveted “Pioneering an impact on Indian industry ...
Read more: Brinton Pharma Gets Top Award for Pioneering an Impact on Indian Industry - Headlines of Today

Pharma Reviews: Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

Fexofinadine is a very established anti-allergy drug with a market size ... anti-allergy drug Fexofinadine Hydrochloride that is marketed in India ...
Read more: Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

Pharma Reviews: market: Indices report biggest single-day gain in a month - The Economic Times

Power Grid Corp. of India, Tata Steel, Sun Pharmaceutical Industries, Tech Mahindra and HCL Technologies gained 2.5-3.7%. India's indices had fallen ...
Read more: market: Indices report biggest single-day gain in a month - The Economic Times

Pharma Reviews: 10th Indian Pharma Expo to be held from 10-11 December in Delhi

IPE offers opportunities for the participating companies to meet, showcase and promote their products and services to visitors from the pharma and ...
Read more: 10th Indian Pharma Expo to be held from 10-11 December in Delhi

Pharma Reviews: Market LIVE: Sensex falls 200 pts, Nifty at 17,350; FMCG, Pharma stocks drag - Mint

Why Emkay sees more upside on multibagger stock that has rallied over 188% this year · Sensex drops 200 points · India services PMI remains elevated in ...
Read more: Market LIVE: Sensex falls 200 pts, Nifty at 17,350; FMCG, Pharma stocks drag - Mint

Pharma Reviews: Pharma Sector - R&D Productivity Long Term Trend (FY11-FY21) – Who Is Doing It Better?: Nirmal ...

... expenditure to U.S. sales for the top Indian pharmaceutical companies exporting to the U.S. Lupin Aurobindo Pharma Cadila Healthcare Ltd., ...
Read more: Pharma Sector - R&D Productivity Long Term Trend (FY11-FY21) – Who Is Doing It Better?: Nirmal ...

Pharma Reviews: ZyCoV-D to be used in seven states initially - Express Pharma

“Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world's first Plasmid DNA Vaccine, to the Government of India at Rs 265 ...
Read more: ZyCoV-D to be used in seven states initially - Express Pharma

Pharma Reviews: Brinton Pharma gets top award for pioneering an impact on Indian industry - Healthcare – ThePrint

With its market value predicted to reach $ 35 billion by 2025 as per Mckinsey report, ambitious Indian pharma companies now want to expand into ...
Read more: Brinton Pharma gets top award for pioneering an impact on Indian industry - Healthcare – ThePrint

US FDA News: August 7, 2019 UPDATE: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents Potentially Associated with Increased Mortality

The FDA is providing updated information about a late mortality signal in patients treated for peripheral artery disease (PAD) in the femoropopliteal artery with paclitaxel-coated balloons and paclitaxel-eluting stents. This communication updates the January 17 and March 15, 2019 notifications.
Read more: August 7, 2019 UPDATE: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents Potentially Associated with Increased Mortality

US FDA News: Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping

Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion of lot SAB06761A experienced a temperature excursion during shipment. Enoxaparin Sodium for Injectio
Read more: Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL Due to Temperature Excursion During Shipping

US FDA News: FDA Proposes Changes to Food Safety Modernization Act Rule to Enhance Safety of Agricultural Water Used on Produce

The FDA issued a proposed rule that aims to enhance the safety of produce and if finalized would require certain farms to evaluate potential contamination risks for the water used on crops before harvest and take additional mitigation measures to help protect public health.
Read more: FDA Proposes Changes to Food Safety Modernization Act Rule to Enhance Safety of Agricultural Water Used on Produce

Pharma Reviews: CCI Releases Its Findings Of The Market Study On The Pharmaceutical Sector In India - Mondaq

On November 18, 2021, the Competition Commission of India ("CCI") published the findings of its market study ("Study") on the pharmaceutical ...
Read more: CCI Releases Its Findings Of The Market Study On The Pharmaceutical Sector In India - Mondaq

Pharma Reviews: Pharma Education & Research (Amendment) Bill, 2021 to be tabled in LS: What it does, why ...

As per PRS India, functions of the Council include: (i) advising on matters ... He also highlighted the progress made by the pharma sector in the ...
Read more: Pharma Education & Research (Amendment) Bill, 2021 to be tabled in LS: What it does, why ...

Pharma Reviews: Brinton Pharma gets top award for pioneering an impact on Indian industry - Healthcare - ANI News

Pune (Maharashtra) [India], December 2 (ANI/NewsVoir): Rahulkumar Darda, Chairman and Managing Director, Brinton Pharmaceuticals received the ...
Read more: Brinton Pharma gets top award for pioneering an impact on Indian industry - Healthcare - ANI News

Pharma Reviews: Serum Institute seeks DCGI's approval for Covishield as booster dose - Express Pharma

Serum Institute of India has sought from India's drug regulator ... Covaxin and Covishield: The Sun and the Moon of Indian vaccine industry.
Read more: Serum Institute seeks DCGI's approval for Covishield as booster dose - Express Pharma

Pharma Reviews: Biocon enters Dow Jones Sustainability Emerging Markets Index - Express Pharma

It is among the top 15 companies from India and one of the 12 companies from the pharmaceuticals, biotechnology and lifesciences sectors to be ...
Read more: Biocon enters Dow Jones Sustainability Emerging Markets Index - Express Pharma

Pharma Reviews: Nifty forms bullish candle; what does it signal for Thursday's trade? - The Economic Times

Indian equities reversed its course following recovery in global markets and strong ... Pharma names came under pressure but autos climbed on ...
Read more: Nifty forms bullish candle; what does it signal for Thursday's trade? - The Economic Times

Pharma Reviews: Share Market Highlights: Sensex soars 619 pts to end at 57684, Nifty 50 index closes at 17166

Share Market News Today | Sensex, Nifty, Share Prices Highlights: Domestic equity ... that India, Indian industry, and Indian citizens are facing.
Read more: Share Market Highlights: Sensex soars 619 pts to end at 57684, Nifty 50 index closes at 17166

Pharma Reviews: Market Live Updates: Sensex rises 200 points in early deals, Nifty above 17200-mark

Share Market Live, Stock Market Today Live, Market Live Updates: Catch all ... pharma and FMCG stocks were capped by fears about the new Omicron ...
Read more: Market Live Updates: Sensex rises 200 points in early deals, Nifty above 17200-mark

Pharma Reviews: Market LIVE: Sensex crosses 58.1k, Nifty near 17.3k; pharma, oil & gas shine - Mint

SGX Nifty futures traded at 17,122.50 in early deals, up 122.5 points or 0.71%, which indicated a negative start for Indian benchmarks in today's ...
Read more: Market LIVE: Sensex crosses 58.1k, Nifty near 17.3k; pharma, oil & gas shine - Mint

Pharma Reviews: Covaxin and Covishield: The Sun and the Moon of Indian vaccine industry - Express Pharma

Sudhir Phatak, Founder, Futorol Consultancy Services, explains how Bharat Biotech, like the sun, with its own R&D, has self-illuminated by ...
Read more: Covaxin and Covishield: The Sun and the Moon of Indian vaccine industry - Express Pharma

Pharma Reviews: Top Indian Mutual Funds On Market Correction, Sectoral Bets and Omicron Scare - Bloomberg Quint

In terms of sectoral bets, ICICI MF is overweight on auto, telecom and pharma sectors and underweight on consumer non-durables and software. Axis MF ...
Read more: Top Indian Mutual Funds On Market Correction, Sectoral Bets and Omicron Scare - Bloomberg Quint

Pharma Reviews: Live news: Economy gathers steam as India braces for Omicron impact - Business Standard

Live news: Economy gathers steam as India braces for Omicron impact ... Without innovation Indian pharma cannot touch $130 bn by 2030: Industry.
Read more: Live news: Economy gathers steam as India braces for Omicron impact - Business Standard

Pharma Reviews: Sun Pharma arm settles case with Biofrontera, to get $22.5 million

By Press Trust of India On Dec 1, 2021. 0 22. Share. Read Article. Sun Pharmaceutical yesterday said its arm DUSA Pharmaceuticals Inc has reached ...
Read more: Sun Pharma arm settles case with Biofrontera, to get $22.5 million

Pharma Reviews: West has been experimenting with products to build vials that are compatible with many ...

How has COVID-19 changed the dynamics of the pharma packaging segment? ... Is the Indian market prepared to leverage the potential of these ...
Read more: West has been experimenting with products to build vials that are compatible with many ...

Pharma Reviews: Stock market update: Nifty Pharma index falls 1.62% - The Economic Times

Shares of De Nora India, KDDL Ltd, Mirza Intnl, Sirca Paints and Bhagyanagar Properti hit their fresh 52-week highs in today's trade, ...
Read more: Stock market update: Nifty Pharma index falls 1.62% - The Economic Times

US FDA News: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics’ Precice Devices – Letter to Health Care Providers

Recommendations for Precice devices due to ongoing biocompatibility evaluation.
Read more: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics’ Precice Devices – Letter to Health Care Providers

US FDA News: UPDATE: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics’ Precice Devices - Letter to Health Care Providers

The FDA is updating recommendations for NuVasive titanium-based Precice devices.
Read more: UPDATE: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics’ Precice Devices - Letter to Health Care Providers

Pharma Reviews: View | Competition Commission'S Fault-Line Navigation In Pharma Sector Market Study

The Covid-19 pandemic has kept the focus on the pharmaceutical sector. In an iteration of such focus, the Competition Commission of India (CCI) ...
Read more: View | Competition Commission'S Fault-Line Navigation In Pharma Sector Market Study

Pharma Reviews: Stocks in news: Maruti Suzuki, NTPC, Axis Bank, Zomato and more - BusinessToday

Indian benchmark indices are likely to open higher today as SGX Nifty rose 58 ... Sun Pharmaceutical Industries: The drug major said its arm DUSA ...
Read more: Stocks in news: Maruti Suzuki, NTPC, Axis Bank, Zomato and more - BusinessToday

Pharma Reviews: Indian pharma upbeat as USFDA panel backs Covid-19 pill - The Financial Express

It typically needs to be administered at an early stage during the onset of the virus and today almost a dozen Indian pharma companies are ready ...
Read more: Indian pharma upbeat as USFDA panel backs Covid-19 pill - The Financial Express